Rapid On-site Cytopathologic Evaluation in the Diagnosis of Hilar/Mediastinal Adenopathy

This study has been completed.
Information provided by:
Maggiore Bellaria Hospital, Bologna
ClinicalTrials.gov Identifier:
First received: June 4, 2009
Last updated: February 18, 2010
Last verified: February 2010

The purpose of this study is to determine whether rapid on-site cytopathologic evaluation (ROSE) can increase the diagnostic yield of transbronchial needle aspiration (TBNA) in the diagnosis of hilar and mediastinal lymphadenopathy.

Condition Intervention
Lung Cancer
Procedure: Rapid on-site cytopathologic evaluation (ROSE)
Procedure: TBNA

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Masking: Open Label
Primary Purpose: Diagnostic
Official Title: Transbronchial Needle Aspiration With and Without Rapid On-site Cytopathologic Evaluation in the Diagnostic Approach to Hilar/Mediastinal Adenopathy: A Randomized Controlled Trial.

Resource links provided by NLM:

Further study details as provided by Maggiore Bellaria Hospital, Bologna:

Primary Outcome Measures:
  • Examine the diagnostic yield of the TBNA with ROSE arm versus the diagnostic yield of TBNA alone arm [ Time Frame: 6-12 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Examine the percentage of inadequate samples in the TBNA with ROSE arm versus the TBNA alone arm [ Time Frame: 6-12 months ] [ Designated as safety issue: No ]
  • Examine the number of biopsy sites in the TBNA with ROSE arm versus the TBNA alone arm [ Time Frame: 6-12 months ] [ Designated as safety issue: No ]
  • Examine the complication rate of bronchoscopy in the TBNA with ROSE arm versus the TBNA alone arm [ Time Frame: 6-12 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 164
Study Start Date: May 2009
Study Completion Date: February 2010
Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: TBNA alone
Arm A: TBNA alone.
Procedure: TBNA
transbronchial needle aspiration
Experimental: TBNA with ROSE
Arm B: TBNA with ROSE.
Procedure: Rapid on-site cytopathologic evaluation (ROSE)
ROSE: examination in the endoscopy suite, by a pathologist, during the bronchoscopic procedure, of samples obtained with transbronchial needle aspiration.
Procedure: TBNA
transbronchial needle aspiration


Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 18 years old and older
  • Hilar and/or mediastinal lymphadenopathy (> 1 cm on the short axis, as assessed by contrast-enhanced CT scan (computed tomography))

Exclusion Criteria:

  • Uncontrolled coagulopathy
  • Refusal to sign informed consent
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00915330

Maggiore Hospital
Bologna, Italy, 40133
Sponsors and Collaborators
Maggiore Bellaria Hospital, Bologna
Principal Investigator: Marco Patelli, MD Maggiore Hospital
  More Information

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Marco Patelli, Maggiore Bellaria Hospital
ClinicalTrials.gov Identifier: NCT00915330     History of Changes
Other Study ID Numbers: 01-Trisolini
Study First Received: June 4, 2009
Last Updated: February 18, 2010
Health Authority: Italy: Ethics Committee

Keywords provided by Maggiore Bellaria Hospital, Bologna:
Transbronchial needle aspiration
Rapid on-site cytopathologic evaluation
Mediastinal lymphadenopathy
Hilar Lymphadenopathy

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Lung Diseases
Respiratory Tract Diseases
Lymphoproliferative Disorders
Lymphatic Diseases
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on August 26, 2014